Skip to main content
. Author manuscript; available in PMC: 2008 Oct 8.
Published in final edited form as: HIV Med. 2008 Apr;9(4):196–202. doi: 10.1111/j.1468-1293.2008.00545.x

Table 3.

Bivariate and multivariate analysis of factors associated with hazardous alcohol use compared to none

Variable Bivariate OR (95% CI) Multivariate OR (95% CI)
Sex
 Female 1.0 (Ref) 1.0 (Ref)
 Male 1.54 (0.93–2.56)** 1.34 (0.78–2.40)
Age
 18–34 1.0 (Ref)
 35–44 1.70 (0.70–4.15)
 ≥ 45 1.28 (0.52–3.12)
Race
 White 1.0 (Ref) 1.0 (Ref)
 African American 0.81 (0.46–1.43) 0.81 (0.45–1.48)
 Hispanic 1.45 (0.72–2.93) 1.71 (0.82–3.57)
 Other 0.25 (0.03–1.90)** 0.22 (0.03–1.77)
Education
 < High school degree 1.0 (Ref)
 High school or junior college 1.26 (0.75–2.13)
 College or post-college 0.71 (0.31–1.60)
Insurance
 Private 1.0 (Ref) 1.0 (Ref)
 Medicaid 1.01 (0.52–1.99) 1.18 (0.58–2.41)
 Medicare 1.30 (0.56–3.03) 1.51 (0.63–3.63)
 Medicaid/Medicare 0.91 (0.44–1.87) 1.06 (0.50–2.24)
 None 1.76 (0.80–3.86)** 1.85 (0.82–4.20)
HAART
 No 1.0 (Ref)
 Yes 1.18 (0.74–1.89)
CD4 nadir (cells/μL)
 < 50 1.0 (Ref) 1.0 (Ref)
 50–199 1.46 (0.79–2.68) 1.70 (0.89–2.23)
 200–499 1.39 (0.75–2.58) 1.64 (0.86–3.15)
 ≥ 500 2.57 (1.25–5.32)* 2.65 (1.23–5.69)*
 Missing 1.94 (0.70–5.40) 1.97 (0.67–5.76)
Illicit drug use
 Never 1.0 (Ref) 1.0 (Ref)
 Former 1.21 (0.65–2.24) 1.22 (0.65–2.33)
 Current 2.40 (1.37–4.23)* 2.67 (1.48–4.82)*
Outpatient psychiatric treatment
 No 1.0 (Ref)
 Yes 0.82 (0.51–1.30)
Primary care visits
 ≤ 3 visits 1.0 (Ref) 1.0 (Ref)
 4–5 visits 0.54 (0.26–1.11)** 0.58 (0.27–1.21)*
 6–7 visits 0.72 (0.40–1.26) 0.79 (0.43–1.40)
 ≥ 8 visits 0.40 (0.21–0.75)* 0.45 (0.23–0.86)*

Multivariate analysis includes only those covariates with P < 0.20 in bivariate analysis. Both bivariate and multivariate analyses adjusted for site. CI, confidence interval; HAART, highly active antiretroviral therapy; OR, odds ratio.

*

P < 0.05.

**

P < 0.20.